Market Overview:
DTaP and Tdap vaccines are used to prevent diphtheria, tetanus, and pertussis (whooping cough) in adults and children. The global DTaP and Tdap vaccines market is expected to grow from USD 3.5 billion in 2018 to USD 6.8 billion by 2030, at a CAGR of 8.9% during the forecast period. The growth of this market is mainly driven by the increasing incidence of diphtheria, tetanus, and pertussis (DTP) infections; rising demand for adult DTaP/Tdap vaccination; growing number of immunization programs across the globe; and technological advancements in vaccine development process.
Product Definition:
DTaP and Tdap vaccines are used to protect children and adults from disease caused by the bacteria that can cause tetanus, diphtheria, and pertussis (whooping cough). DTaP is for use in children younger than 7 years old. Tdap is for use in adolescents and adults.
DTaP:
DTaP, or diphtheria, tetanus and pertussis is a vaccine used to prevent people from getting these diseases. DTaP vaccines are usually given as a single dose in children between the age of five and nine years and as multiple doses in adults. The Centers for Disease Control (CDC) recommends that all children should be vaccinated against diphtheria, tetanus and pertussis (DTaP).
Td:
Tetanus, diphtheria, and pertussis are known as the tetanus and diphtheria toxin (TD) family. These are among the most fatal diseases in children. The disease is caused by bacteria that enter through a wound or puncture in the skin. The most common symptom of TD is stiff neck.
Application Insights:
On the basis of application, the global DTaP and Tdap vaccines market is categorized into adult and pediatric. The adult segment held a larger share in 2017 as compared to the pediatric segment. This is due to factors such as higher population of adults in developed countries such as U.S., Canada, Germany, France etc. than that of developing countries like India China Brazil etc.
The growing importance of measles-mumps-rubella (MMR) vaccine among adults due to increasing awareness about immunization against this disease coupled with rising incidence rate has led to an increase in demand for these vaccines among them which ultimately resulted in a larger share for this segment over that one year period ending 2018.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing awareness about child immunization, high purchasing power of consumers, and presence of a large number of vaccine manufacturers in this region. The U.S., which is the largest market for vaccines globally, has witnessed an increase in demand for pediatric vaccines over the past few years due to rising incidence of diseases such as whooping cough and measles among other infections.
Asia Pacific is expected to witness significant growth during the forecast period owing to rise in target population base along with growing prevalence rate of infectious diseases such as diphtheria, tetanus & pertussis (whooping cough). In addition, introduction and development DTaP/Tdap vaccination programs are also contributing towards regional growth.
Growth Factors:
- Increasing incidence of diphtheria, pertussis and tetanus (DPT) in developing countries
- Growing awareness about the benefits of DTaP and Tdap vaccines among parents
- Rising demand for pediatric vaccines globally
- Technological advancements in vaccine development process
- increasing number of immunization programs by governments and non-profit organizations
Scope Of The Report
Report Attributes
Report Details
Report Title
DTaP and Tdap Vaccines Market Research Report
By Type
DTaP, Td, Tdap
By Application
Adult, Pediatric
By Companies
Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc, Pfizer Inc, Johnson & Johnson, Lanzhou Institute of Biological Products Co., Ltd, Sanofi Pasteur, Emergent BioSolutions Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global DTaP and Tdap Vaccines Market Report Segments:
The global DTaP and Tdap Vaccines market is segmented on the basis of:
Types
DTaP, Td, Tdap
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Pediatric
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi Pasteur
- GlaxoSmithKline
- Protein Sciences Corporation
- Novartis AG
- Seqirus
- Merck Sharp & Dohme Corp
- Astellas Pharma US, Inc
- Pfizer Inc
- Johnson & Johnson
- Lanzhou Institute of Biological Products Co., Ltd
- Sanofi Pasteur
- Emergent BioSolutions Inc
Highlights of The DTaP and Tdap Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DTaP
- Td
- Tdap
- By Application:
- Adult
- Pediatric
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DTaP and Tdap Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DTaP vaccines are a series of shots given to children between the ages of 2 and 6 years old. Tdap vaccines are a series of shots given to adults over age 50 years.
Some of the key players operating in the dtap and tdap vaccines market are Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc, Pfizer Inc, Johnson & Johnson, Lanzhou Institute of Biological Products Co., Ltd, Sanofi Pasteur, Emergent BioSolutions Inc.
The dtap and tdap vaccines market is expected to grow at a compound annual growth rate of 8.9%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DTaP and Tdap Vaccines Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 DTaP and Tdap Vaccines Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 DTaP and Tdap Vaccines Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the DTaP and Tdap Vaccines Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global DTaP and Tdap Vaccines Market Size & Forecast, 2020-2028 4.5.1 DTaP and Tdap Vaccines Market Size and Y-o-Y Growth 4.5.2 DTaP and Tdap Vaccines Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DTaP
5.2.2 Td
5.2.3 Tdap
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Pediatric
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DTaP and Tdap Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DTaP and Tdap Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DTaP
9.6.2 Td
9.6.3 Tdap
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Pediatric
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DTaP
10.6.2 Td
10.6.3 Tdap
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Pediatric
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DTaP
11.6.2 Td
11.6.3 Tdap
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Pediatric
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DTaP
12.6.2 Td
12.6.3 Tdap
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Pediatric
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DTaP
13.6.2 Td
13.6.3 Tdap
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Pediatric
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DTaP and Tdap Vaccines Market: Competitive Dashboard
14.2 Global DTaP and Tdap Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi Pasteur
14.3.2 GlaxoSmithKline
14.3.3 Protein Sciences Corporation
14.3.4 Novartis AG
14.3.5 Seqirus
14.3.6 Merck Sharp & Dohme Corp
14.3.7 Astellas Pharma US, Inc
14.3.8 Pfizer Inc
14.3.9 Johnson & Johnson
14.3.10 Lanzhou Institute of Biological Products Co., Ltd
14.3.11 Sanofi Pasteur
14.3.12 Emergent BioSolutions Inc